Amgen
Evenity
Biodrugs/ Drugs
Genetic Diseases and Dysmorphic syndromes
A Randomized, Double blind, Placebo controlled, Ascending Multiple dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Romosozumab in Children and Adolescents with Osteogenesis Imperfecta
1Phase I in Spain